NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Depending on the type of cancer, it can be used as monotherapy or combination as a part of first line regimen, maintenance regimen or relapsed settings
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
Daffodils by Artemis is a premiere luxury birthing centre offering mother and child care services.
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Subject Expert Committee(SEC) of Central Drugs Standard Control Organization (CDSCO)
The book “Science behind Suryanamaskar” has been compiled by the AIIA’s Department of Swasthavritta and Yoga.
Indonesia national agency for drug and food control, BPOM, approved QDENGA for use in individuals 6 to 45 years of age
The drive also conducted a mega health camp, cancer screening for women and men, ENT screening for children, and blood donation drive
The Sri Sathya Sai Sanjeevani Super Speciality Hospital in Batticaloa will begin its operations by conducting free paediatric cardiac care surgeries and interventions in the next few days
Subscribe To Our Newsletter & Stay Updated
